Romania – Medical equipments – Echipamente medicale
Romania – Medical equipments – Echipamente medicale
Don't miss the next one like this
New health grants in ROU open all the time. Get a free weekly email with only the ones that match — nothing else.
Want help winning this?
Enter your email and we'll send the official application link, deadlines and pointers right away — free. Want a hand? Tick the box and we'll introduce you to a vetted grant or bid writer. The intro's free, and you only pay if you choose to work with them.
Related opportunities
See all alternatives →Romania – Surgical implants – MATERIALE SANITARE 1 (2026)
→Romania – Surgical implants – MATERIALE SANITARE 1 (2026)
Tender$2.3MCloses in 5 daysROUHealthRomania – Laboratory reagents – Acord-cadru de furnizare pachete de reactivi si consumabile compatibile sau echivalente cu aparatele din dotare, 2026-III
→Romania – Laboratory reagents – Acord-cadru de furnizare pachete de reactivi si consumabile compatibile sau echivalente cu aparatele din dotare, 2026-III
Tender$1.8MCloses 2026-10-21ROUHealthRomania – Medical equipments – Achiziție aparatură și echipamente spital
→Romania – Medical equipments – Achiziție aparatură și echipamente spital
Tender$832KCloses in 9 daysROUHealthRomania – Laboratory reagents – Reactivi si consumabile de laborator -5 loturi in cadrul proiectului de cercetare „PN-IV-P6-6.1-CoEx-2024-0029; contract nr. 10CoEX/2026
→Romania – Laboratory reagents – Reactivi si consumabile de laborator -5 loturi in cadrul proiectului de cercetare „PN-IV-P6-6.1-CoEx-2024-0029; contract nr. 10CoEX/2026
Tender$38KCloses 2026-10-19ROUHealthDecode the Immunoscience of age-related diseases
→Expected Impact: The action under this topic is expected to achieve the following impacts: Accelerate EU access to more cost-effective interventions in an increasingly ageing population by identifying personalised treatment approaches for elderly-onset immune diseases. Decrease disease risk later in life by defining specific prevention strategies based on ageing biomarkers and risk factors. Halt age-associated disease exacerbation by the identification of predictive and digital biomarkers that can stratify patients for early intervention. Improve quality of life for healthy individuals and patients by preventing further health decline, avoiding escalating care costs, and properly stratifying individuals earlier in the diagnostic pathway. Accelerate adoption of innovative diagnostic, preventative, and therapeutic strategies, strengthening the EU’s position as a healthcare innovator. Evaluate digital biomarker as potential regulatory endpoints in the ultimate goal to develop medicines for ‘healthy ageing’. Integrate fragmented research efforts by bringing together health industry sectors and stakeholders to develop clinical and multi-omics data integration capabilities. Enable new…
Grant$10.7MCloses in 8 daysEUHealthNeutral-Atom Platform Technologies
→Expected Outcome: This action aims to establish European leadership in neutral-atom quantum simulation and digital quantum computing by delivering: Fully programmable industry-ready quantum simulators based on 10.000 neutral atoms in a scalable architecture, accessible via cloud platforms, and with the possibility of integrating them into high-performance computing environments. Fully programmable platform for neutral-atom quantum computing capable of both analogue quantum operations and gate-based computing with 1.000 physical qubits and a clear path to further scalability to 10.000 physical qubits. Coherence time of the order of hundreds of interaction times and infidelity of operations below 1%. Demonstration of quantum simulation and/or computing operating beyond classical computability, validated through benchmarking with classical methods. New real-world applications across science and industry (at least two) (e.g: in the energy and health sectors) The software stack for these applications, including enhanced software for verification, algorithm implementation, and user programming interfaces. Demonstration of the full quantum stack – including quantum control, electronic…
Grant$22.8MCloses 2026-11-17EUHealth
People also viewed
Other grants visitors looked at from Spitalul Municipal Campulung Muscel.
Superconducting Platform Technologies
→Expected Outcome: This action will consolidate Europe’s position in superconducting quantum computing through: Establishment of a full-stack superconducting quantum computer aiming at 1.000 physical qubits and QPU architecture based on chiplet technology. The system should feature a scalable and user-adjustable architecture, T1 coherence time above 100 us, gate fidelities (both one- and two-qubit gates, and read-out) of at least 99.9%, read-out speed below 300 ns, two-qubit gate speed below 20 ns. Demonstration of quantum advantage on selected industrial use cases, validated through benchmarking with best-in-class classical methods. Deployment of a cloud-accessible quantum system integrated with high-performance computing environments. Maturation of fault-tolerant quantum computing protocols, including effective quantum error correction and noise mitigation schemes. Delivery of a comprehensive, standardised software stack supporting system bring-up, calibration, control, benchmarking, and user access. Strengthened supply chains and industrial capacity in Europe for superconducting quantum technologies. Scope: The proposal should contribute to the scale-up and practical deployment…
Grant$22.8MCloses 2026-11-17EUResearchQuantum Experimental Pilot Lines for Quantum Technologies
→Expected Outcome: This action will strengthen Europe's leadership and strategic autonomy in quantum technologies by advancing experimental pilot line capacities as a vital stepping stone toward future industrial-scale quantum hardware production. Qu-Pilot serves as the critical intermediary between academic research and the stable pilot lines under the Chips Joint Undertaking, offering a testbed for technological innovation, reproducibility, and manufacturability. Expected outcomes include: Deployment of experimental quantum pilot lines addressing diverse platforms and materials, laying the groundwork for broader integration into Chips JU pilot lines. Establishment of scalable and reproducible quantum fabrication processes, advancing TRL 4–6 technologies and addressing early-stage certification, standardisation, and quality control. Reinforcement of a pan-European quantum hardware ecosystem through shared infrastructure and open-access models, fostering participation from SMEs, startups, and research institutes. Demonstrated ability to accelerate technology maturity and feed critical feedback loops into future Chips JU stability pilot lines. Enhanced synergies with testing…
Grant$17.1MCloses 2026-11-17EUResearchTrapped-Ion Platform Technologies
→Expected Outcome: This action will advance Europe’s leadership in trapped-ion quantum computing by achieving the following key outcomes: Establishment of a full-stack ion-trap quantum computer aiming at more than 1.000 qubits, fully integrated into high-performance computing (HPC) systems, and accessible via the cloud. Demonstration of quantum advantage for selected real-world applications, validated against benchmarks. Strengthened European capabilities to develop modular, interoperable, and scalable quantum computing architectures. Implementation and demonstration of advanced error correction and fault-tolerant quantum computing techniques. Integration of full-stack hardware-software systems with standardised and certified interfaces. Engagement with industry and academia through open access to quantum computing resources and co-design of applications. Scope: The action should support the scale-up of European trapped-ion quantum computing platforms, aiming at technological maturity and usability for industrial and scientific applications. In particular, the action must address at least two major technical roadblocks defined in the Strategic Research and Industry Agenda (SRIA…
Grant$22.8MCloses 2026-11-17EUResearchQuantum-Testing Infrastructure for Quantum Technologies
→Expected Outcome: This action will establish a pan-European open-access testing and experimentation infrastructure for quantum technologies, enabling systematic validation and certification of quantum components and systems. Expected outcomes include: Deployment of distributed quantum testing facilities accessible across Europe, including remote access and standardized test protocols. Provision of certification services aligned with future standardisation efforts, ensuring trust, quality, and interoperability of quantum technologies. Support for SMEs, start-ups, and research institutions in validating quantum components and sub-systems. Strengthening of Europe’s competitiveness by ensuring robust quality assurance mechanisms and accelerating the time-to-market of emerging quantum products. Scope: The proposal should implement the testing-related part of the action plan established under the Framework Partnership Agreement for Qu-Test. The action must include: Expansion and interconnection of open-access testing facilities in multiple Member States, covering a range of quantum technologies (e.g., processors, sensors, photonics, control systems). Development and deployment of…
Grant$22.8MCloses 2026-11-17EUResearch
Always confirm details on the official source before applying — see our methodology.